Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro.
F CoperchiniA GrecoE PetrosinoL CroceM TelitiN MarchesiA PascaleB CalìP PignattiF MagriM UddinMario RotondiPublished in: Journal of endocrinological investigation (2024)
Our findings confirm the involvement of the CXCL8/CXCR2-axis in promoting pro-tumorigenic effects in TC cells, further demonstrating its immunotherapeutic significance in human cancer.